SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001390478-20-000026
Filing Date
2020-08-13
Accepted
2020-08-13 16:17:12
Documents
63
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q gale-20200630.htm   iXBRL 10-Q 1444306
2 EX-31.1 sls20200630ex311nextgen.htm EX-31.1 10457
3 EX-31.2 sls20200630ex312nextgen.htm EX-31.2 10135
4 EX-32.1 sls20200630ex321nextgen.htm EX-32.1 9753
10 gale-20200630_g1.jpg GRAPHIC 30719
  Complete submission text file 0001390478-20-000026.txt   6210144

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT gale-20200630.xsd EX-101.SCH 43427
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT gale-20200630_cal.xml EX-101.CAL 60818
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT gale-20200630_def.xml EX-101.DEF 199321
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT gale-20200630_lab.xml EX-101.LAB 482772
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT gale-20200630_pre.xml EX-101.PRE 326343
11 EXTRACTED XBRL INSTANCE DOCUMENT gale-20200630_htm.xml XML 1121296
Mailing Address 7 TIMES SQUARE SUITE 2503 NEW YORK NY 10036
Business Address 7 TIMES SQUARE SUITE 2503 NEW YORK NY 10036 6462005278
SELLAS Life Sciences Group, Inc. (Filer) CIK: 0001390478 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33958 | Film No.: 201099555
SIC: 2834 Pharmaceutical Preparations